Proposed California drug pricing program could shift 340B drug reimbursement away from hospitals

Bricker & Eckler LLP

Bricker & Eckler LLP

On January 8, 2019, California Governor Gavin Newsom issued an executive order requiring all state agencies to consolidate into a single drug purchasing entity that will negotiate with pharmaceutical companies together. The scale of such an entity would enable the negotiation of better deals for drugs purchased by the state. However, the executive order could lead to significant losses for California hospitals that are part of the 340B program as all Medicaid managed-care drugs would be moved to Medicaid fee-for-service and California currently has strict regulations governing hospital discounts under the Medicaid fee-for-service program.

While this California program is still only in the early stages of development, providers and analysts fear that it could have significant negative effects on both small and large entities that rely on 340B Program funding, particularly safety net hospitals with large Medicaid patient populations.

If successful, the California program could be a model for other states searching for ways to combat high drug costs, at the cost of 340B savings for struggling safety net hospitals.

For more information on this and other 340B issues see Bricker & Eckler’s prior 340B program updates.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bricker & Eckler LLP | Attorney Advertising

Written by:

Bricker & Eckler LLP

Bricker & Eckler LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.